CHTN OvCa2 - Ovarian Carcinoma Survey 2

TMA Map - Cancer type

CHTN OvCa2 - Ovarian Carcinoma Survey 2 TMA Cancer Type

Back    Return to top

TMA Map - Case ID

CHTN OvCa2 - Ovarian Carcinoma Survey 2 TMA Map Case ID

Back    Return to top

Tissue List

TMA code Diagnosis Age pT stage Grade
SPC-1 Serous papillary carcinoma 62 pT3c [IIIC] high
SPC-2 Serous papillary carcinoma 64 pT3b [IIIB] high
SPC-3 Serous papillary carcinoma 64 pT2a [IIA] high
SPC-4 Serous papillary carcinoma 62 pT3c [IIIC] high
SPC-5 Serous papillary carcinoma 65 pT3a [IIIC] high
SPC-6 Serous papillary carcinoma 74 pT3c [IIIC] high
SPC-7 Serous papillary carcinoma 42 pT2a [IIA] high
SPC-8 Serous papillary carcinoma 45 pT3c [IIIC] high
SPC-9 Serous papillary carcinoma 52 pT3c [IIIC] high
SPC-10 Serous papillary carcinoma 66 pT3c [IIIC] high
SPC-11 Serous papillary carcinoma 64 pT3b [IIIB] high
SPC-121 Serous papillary carcinoma 71 pT3c [IIIC] high
EAC-1 Endometriod adenocarcinoma 58 pT1c [IC] moderate
EAC-2 Endometriod adenocarcinoma 59 pT2c [IIC] moderate
EAC-3 Endometriod adenocarcinoma 67 pT1a [IA] low
EAC-4 Endometriod adenocarcinoma 52 pT1c [IC] low
EAC-5 Endometriod adenocarcinoma 51 pT1c [IC] low
EAC-6 Endometriod adenocarcinoma 52 pT2b [IIB] high
EAC-7 Endometriod adenocarcinoma 65 pT1a [IA] high
EAC-8 Endometriod adenocarcinoma 42 pT3c [IIIC] high
EAC-9 Endometriod adenocarcinoma 49 pT1a high
EAC-10 Endometriod adenocarcinoma 76 pT1c moderate
EAC-11 Endometriod adenocarcinoma 70 pT1a moderate
EAC-121 Endometriod adenocarcinoma 83 pT1c low
CCC-1 Clear cell carcinoma 62 pT1c [IC] high
CCC-2 Clear cell carcinoma 77 pT3a [IIIA] high
CCC-3 Clear cell carcinoma 73 pT2C [IIC] high
CCC-4 Clear cell carcinoma 72 pT1a [IA] high
CCC-5 Clear cell carcinoma 42 pT3a [IIIA] high
CCC-6 Clear cell carcinoma 27 pT3c [IIIC] high
CCC-7 Clear cell carcinoma 46 pT3c [IIIC] high
CCC-8 Clear cell carcinoma 68 pT3a [IIIA] high
CCC-9 Clear cell carcinoma 88 pT1c [IC] high
CCC-10 Clear cell carcinoma 39 pT1a [IA] high
CCC-11 Clear cell carcinoma 76 pT2c [IIC] high
CCC-12 Clear cell carcinoma 50 pT1c high
MAC-1 Mucinous adenocarcinoma 20 pT1a low
MAC-2 Mucinous adenocarcinoma 63 pT1a high
MAC-31 Mucinous adenocarcinoma 57 pT1a high
MAC-4 Mucinous adenocarcinoma 40 pT1a high
MAC-5 Mucinous adenocarcinoma 69 pT3a not assigned
MAC-6 Mucinous adenocarcinoma 43 pT1a low
MAC-7 Mucinous adenocarcinoma 29 pT2b high
MAC-8 Mucinous adenocarcinoma 62 pT3c moderate
MAC-9 Mucinous adenocarcinoma 63 pT1a low
MAC-10 Mucinous adenocarcinoma 66 n/a moderate
SBT-1 Serous borderline tumor 57 pT1c low
SBT-2 Serous borderline tumor 72 pT1a low
SBT-3 Serous borderline tumor 46 pT1c low
SBT-4 Serous borderline tumor 46 pT3a low
SBT-5 Serous borderline tumor 49 pT1c low
SBT-6 Serous borderline tumor 39 pT1C low
MBT-1 Mucinous borderline tumor 70 pT1C low
MBT-2 Mucinous borderline tumor 50 pT1c low
MBT-3 Mucinous borderline tumor 13 n/a low
MBT-4 Mucinous borderline tumor 67 pT1c low
MBT-5 Mucinous borderline tumor 54 pT1a low
MBT-6 Mucinous borderline tumor 49 pT1a low
NPE-1 Normal proliferative endometrium 57 N/A N/A
NPE-2 Normal proliferative endometrium 43 N/A N/A
NPE-3 Normal proliferative endometrium 43 N/A N/A
NPE-4 Normal proliferative endometrium 46 N/A N/A
NPE-5 Normal proliferative endometrium 41 N/A N/A
NPE-6 Normal proliferative endometrium 57 N/A N/A
NFT-1 Normal fallopian tube fimbriae 67 N/A N/A
NFT-2 Normal fallopian tube fimbriae 61 N/A N/A
NFT-31 Normal fallopian tube fimbriae 47 N/A N/A
NFT-4 Normal fallopian tube fimbriae 61 N/A N/A
NFT-5 Normal fallopian tube fimbriae 75 N/A N/A
NFT-6 Normal fallopian tube fimbriae 64 N/A N/A
SCA-1 Serous cystadenoma 50 N/A N/A
SCA-2 Serous cystadenoma 71 N/A N/A
SCA-31 Serous cystadenoma 76 N/A N/A
SCA-41 Serous cystadenoma 53 N/A N/A
SCA-5 Serous cystadenoma 46 N/A N/A
SCA-61 Serous cystadenoma 74 N/A N/A
MCA-1 Mucinous cystadenoma 51 N/A N/A
MCA-2 Mucinous cystadenoma 42 N/A N/A
MCA-3 Mucinous cystadenoma 60 N/A N/A
MCA-4 Mucinous cystadenoma 76 N/A N/A
MCA-5 Mucinous cystadenoma 42 N/A N/A
MCA-6 Mucinous cystadenoma 25 N/A N/A

1These cases sampled with additional cores due to difficult target tissue.

Back    Return to top